585
Views
84
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Tumor Necrosis Factor-α in Liver Ischemia/Reperfusion Injury

, , &
Pages 178-188 | Received 12 Feb 2011, Accepted 22 Feb 2011, Published online: 15 Jun 2011

REFERENCES

  • Liu DL, Jeppsson B, Hakansson CH, Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg. 1996;131:442–447.
  • Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg. 1994;178:454–458.
  • Vedder NB, Fouty BW, Winn RK, Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery. 1989;106:509–516.
  • Lentsch AB, Kato A, Yoshidome H, Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169–173.
  • Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Phamacol Toxicol. 1997;37:327–338.
  • Jaeschke H, Smith CV, Mitchell JR. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest. 1988;81:1240–1246.
  • Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interactions. 1991;79:115–136.
  • Jaeschke H, Bautista AP, Spolarics Z, Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun.1991;15:277–284.
  • Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol. 1991;260:G355–G362.
  • Jaeschke H, Farhood A, Bautista AP, Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol. 1993;264:G801–G809.
  • Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurg. 1993;14:165–175.
  • Lichtman SN, Lemasters JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis. 1999;19:171–187.
  • Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181:160–166.
  • Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18:891–902.
  • Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15–G26.
  • Colletti LM, Remick DG, Burtch GD, Role of tumor necrosis factor-αlpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990;85:1936–1943.
  • Colletti LM, Kunkel SL, Walz A, The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology. 1996; 23:506–514.
  • Hisama N, Yamaguchi Y, Ishiko T, Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology. 1996;24:1193–1198.
  • Wanner GA, Ertel W, Muller P, Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock. 1996;5:34–40.
  • Suzuki S, Toledo-Pereyra LH. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res. 1994;57:253–258.
  • Bradham CA, Schemmer P, Stachlewitz RF, Activation of nuclear factor-κB during orthotopic liver transplantation in rats is protective and does not require kupffer cells. Liver Trans Surg. 1999;5:282–293.
  • Lentsch AB, Yoshidome H, Kato A, Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology. 1999;30:1448–1453.
  • Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med. 1993;21:S447–S463.
  • Bradham CA, Plümpe J, Manns MP, Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol. 1998;275:G387–G392.
  • Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995;81:495–504.
  • Yamada Y, Webber EM, Kirillova I, Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology.1998;28:959–970.
  • Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost. 2007;97:738–774.
  • Hensley K, Robinson KA, Gabbita SP, Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med. 2000;28:1456–1462.
  • Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB. 1990;4:3355–3359.
  • Jaeschke H, Ho YS, Fisher MA, Glutathione peroxidase–deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology. 1999;29:443–450.
  • Liu P, McQuire GM, Fisher MA, Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ Shock. 1994;43:64–70.
  • Bilzer M, Jaeschke H, Vollmar AM, Prevention of kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol. 1999;276:G1137–G1144.
  • Yabe Y, Kobayashi N, Nishihashi T, Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther. 2001;298:894–899.
  • Witthaut R, Farhood A, Smith CW, Complement and tumor necrosis factor-alpha contribute to Mac-1 (CD11b/CD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo. J Leukoc Biol. 1994;55:105–111.
  • Bajt ML, Farhood A, Jaeschke H. Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1188–G1195.
  • Shirasugi N, Wakabayashi G, Shimazu M. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation. 1997;64:1398–1403.
  • Shito M, Wakabayashi G, Ueda M, Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation. 1997;63:143–148.
  • Kato A, Gabay C, Okaya T, Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol. 2002;161:1797–1803.
  • Liu P, Xu B, Spokas E, Role of endogenous nitric oxide in TNF-α and IL-1β generation in hepatic ischemia-reperfusion. Shock. 2000;13:217–223.
  • Rodríguez-Reynoso S, Leal C, Portilla E, Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-α and nitric oxide. J Surg Research. 2001;100: 141–149.
  • Yoshidome H, Lentsch AB, Cheadle WG, Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J Surg Research. 1999;81:33–37.
  • McCurry KR, Campbell DA Jr, Scales WE, Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Research. 1993;55:49–54.
  • Colletti LM, Kunkel SL, Walz A. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: the role of epithelial neutrophil activating protein. J Clin Invest. 1995;95:134–141.
  • Marubayashi S, Oshiro Y, Fukuma A, Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Transplant Proc. 1999;31:1054.
  • Nakano H, Kuzume M, Namatame K, Efficacy of intraportal injection of anti ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am J Surg. 1995;170:64–66.
  • Colletti LM, Cortis A, Lukacs N, Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock. 1998;10:182–191.
  • Peralta C, Fernández L, Panés J, Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology. 2001;33:100–113.
  • Singh I, Zibari GB, Brown MF, Role of P-selectin in hepatic ischemia and reperfusion injury. Clin Transplant. 1999;13:76–82.
  • Zibari GB, Brown MF, Burney N, Role of P-selectin in the recruitment of leukocytes in mouse liver exposed to ischemia and reperfusion. Transplant Proc. 1998;30:2327–2330.
  • Zwacka RM, Zhang Y, Halldorson J, CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest. 1997;100:279–289.
  • Khandoga A, Hanschen M, Kessler JS, CD4(+) T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology. 2006;43:306–315.
  • Hanschen M, Zahler S, Krombach F, Reciprocal activation between CD4+ T cells and kupffer cells during hepatic ischemia-reperfusion. Transplantation. 2008;86:710–718.
  • Zhou M, Yang S, Koo DJ, The role of Kupffer cell α2-adrenoceptors in norepinephrine-induced TNF-α production. Biochimica et Biophysica Acta. 2001;1537: 49–57.
  • Shibuya H, Ohkohchi N, Tsukamoto S, Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver. Hepatology. 1997;26:113–120.
  • Selzner N, Selzner M, Tian Y, Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-alpha/IL-6-dependent mechanism. Hepatology. 2002;36:812–818.
  • Damas P, Reuter A, Gysen P, Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989;17:975–978.
  • Suter PM, Suter S, Girardin E, High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145:1016–1022.
  • Brock RW, Lawlor DK, Harris KA, Initiation of remote hepatic injury in the rat: interactions between Kupffer cells, tumor necrosis factor-α, and microvascular perfusion. Hepatology. 1999;30:137–142.
  • Micheau O, Tschopp J. Induction of TNF receptor 1-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181–190.
  • Malhi H, Gores GJ. Cellular and molecular mechanism of liver injury. Gastroenterology. 2008;134:1641–1654.
  • Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225–226.
  • DiDonato JA, Hayakawa M, Rothwarf DM, A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997;388: 548–554.
  • Rothwarf DM, Zandi E, Natoli G, IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998;395:297–300.
  • Mercurio F, Zhu H, Murray BW, IKK- 1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 1997;278:860–866.
  • Zandi E, Rothwarf DM, Delhase M, The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997;91: 243–252.
  • Zandi E, Chen Y, Karin M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science. 1998;281:1360–1363.
  • Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clinic Rev Allerg Immunol. 2009;36:4–12.
  • Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci. 2004;29:72–77.
  • Zwacka RM, Zhang Y, Zhou W, Ischemia/ reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology. 1998;28:1022–1030.
  • Fan C, Li Q, Ross D, Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J Biol Chem. 2003;278:2072–2080.
  • Luedde T, Assmus U, Wustefeld T, Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/ reperfusion injury. J Clin Invest. 2005;115:849–859.
  • Beraza N, Lüdde T, Assmus U, Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology. 2007;132:2504–2517.
  • Jun X, Jun X, Minsheng B, NF-kappaB/I-kappaB pathway during ischemia reperfusion injury of rat liver. Chinese Med J. 2003;116:1146–1149.
  • Yoshidome H, Kato A, Edwards MJ, Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implication of a central role for nuclear factor kappa B. Hepatology. 1999;30:203–208.
  • Hatano, E. Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol. 2007;Suppl. 1:S43–S44.
  • Ding W, In X. Dissection of the multiple mechanism of TNF-α-induced apoptosis in liver injury. J Cell Mol Med. 2004;8:445–454.
  • Lemasters JJ, Nieminen AL, Qian T, The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta. 1998;1366:177–196.
  • Alessenko AV, Galperin EI, Dudnik LB, Role of tumor necrosis factor alpha and sphinomyelin cycle activation in the induction of apoptosis by ischemia/reperfusion of the liver. Biochemistry (Moscow). 2002;67:1632–1642.
  • Llacuna L, Marí M, Garcia-Ruiz C, Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology. 2006;44:561–572.
  • Lloris-Caris JM, Cejalvo D, Toledo-Pereyra LH, Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc. 1993;25:3303–3304.
  • Yin DP, Sankary HN, Chong AS, Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation. 1998;27:152–157.
  • Peralta C, Prats N, Xaus C, Protective effect of liver preconditioning on liver and lung induced by hepatic ischemia-reperfusion in the rat. Hepatology. 1999;30:1481–1489.
  • Nilsson B, Friman S, Gustafasson BI, Preconditioning protects against ischemia/reperfusion injury of the liver. J Gastrointest Surg. 2000;4:44–49.
  • Clavien PA, Yadav S, Sindram D, Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:163–165.
  • Teoh N, Leclercq I, dela Pena A, Low-dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology. 2003;37:118–128.
  • Teoh N, dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase and cell cycle entry. Hepatology. 2002;36:94–102.
  • Sass G, Shembade ND, Haimerl F, TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax. J Immunol. 2007;179:7042–7049.
  • Clavien PA, Selzner M, Rüdiger HA, A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843–850.
  • Nuzzo G, Giuliante F, Vellone M, Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl. 2004;10:S53–S57.
  • Choukèr A, Martignoni A, Schauer R, Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg. 2005;140:129–136.
  • Koneru B, Fisher A, He Y, Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl. 2005;11:196–202.
  • Azoulay D, Del Gaudio M, Andreani P, Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the Ying and the Yang. Ann Surg. 2005;242:133–139.
  • Jassem W, Fuggle SV, Cerundolo L, Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation. 2006;81:169–174.
  • Cescon M, Grazi GL, Grassi A, Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl. 2006;12:628–635.
  • Amador A, Grande L, Marti J, Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant. 2007;7:2180–2189.
  • Desai KK, Dikdan GS, Shareef A, Ischemic preconditioning of the liver: a few perspectives from the bench to bedside translation. Liver Transplant. 2008;14: 1569–1577.
  • Koneru B, Shareef A, Dikdan G, The ischemic preconditioning paradox in deceased donor liver transplantation: evidence from a prospective randomized single blind clinical trial. Am J Transplant. 2007;7:2788–2796.
  • Yonezawa K, Yamamoto Y, Yamamoto H, Suppression of tumor necrosis factor-α production and neutrophil infiltration during ischemia-reperfusion injury of the liver after heat shock preconditioning. J Hepatol. 2001;35:619–627.
  • Peng XX, Currin RT, Thurman RG, Protection by pentoxifylline against normothermic liver ischemia/ reperfusion in rats. Transplantation. 1995;59:1537–1541.
  • Ben-Ari Z, Hochhauser E, Burstein I, Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environment. Transplantation. 2002;73:1875–1880.
  • Ishii T, Kim Y, Kawano K, Amelioration of tumor necrosis factor release by cyclosporine in warm ischemia/reperfusion injury of the rat liver: with special reference to hepatic ultrastructure. J Hepatobiliary Pancreat Surg. 1999;6:267–274.
  • Colletti LM, Remick DG, Campbell DA Jr. Desferal attenuates TNF release following hepatic ischemia/reperfusion. J Surg Res. 1994;57:447–453.
  • Camargo CA Jr, Madden JF, Gao W, Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology. 1997;26:1513–1520.
  • Yoshidome H, Kato A, Miyazaki M, IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. Am J Pathol. 1999;155:1059–1064.
  • Kiemer AK, Vollmar AM, Bilzer M, Atrial natriuretic peptide reduces expression of TNF-α mRNA during reperfusion of the rat liver upon decreased activation of NF-κB and AP-1. J Hepatol. 2000;33:236–246.
  • Yoshizumi T, Yonemitsu Y, Ikeda Y, Tumor necrosis factor-α antisense transfer remarkably improves hepatic graft viability. Liver Int. 2006;26:451–456.
  • Yuan GJ, Gong ZJ, Sun XM, Tea polyphenols inhibit expression of iNOS and TNF-α and prevent lipopolysaccharide-induced liver injury in rats. Hepatobiliary Pancreat Dis Int. 2006;5:262–267.
  • Tang ZY, Loss G, Carmody I, TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats. Transplantation. 2006;82:1518–1523.
  • López-Neblina F, Toledo-Pereyra LH. Anti-ischemic effect of selectin blocker through modulation of tumor necrosis factor-α and interleukin-10. J Surg Res. 2007;138: 275–283.
  • Pascher A, Klupp J. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury. Biodrugs. 2005;19:211–231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.